| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 01/17/2008 | WO2008008276A2 Tetracycline repressor regulated oncolytic viruses |
| 01/17/2008 | WO2008007581A1 Non-replicating paramyxoviridae virus vector |
| 01/17/2008 | WO2008007021A1 Method of immunisation against the four serotypes of dengue |
| 01/17/2008 | WO2008006780A1 Method for influenza virus purification |
| 01/17/2008 | WO2007016239A3 Herpes simplex virus mutant and uses therefore |
| 01/17/2008 | US20080014626 Method for preparing viral material |
| 01/17/2008 | US20080014625 Adsorptive membranes for trapping viruses |
| 01/17/2008 | US20080014624 Isolated cDNA or RNA molecule that encodes a protein of given amino acid sequence; cDNA or RNA comprising a nucleotide sequence; can use for vaccines and chemotherapeutic drugs |
| 01/17/2008 | CA2658266A1 Non-replicating paramyxoviridae virus vector |
| 01/17/2008 | CA2657648A1 Virosomes, methods of preparation, and immunogenic compositions |
| 01/17/2008 | CA2656349A1 Method of immunisation against the four serotypes of dengue |
| 01/16/2008 | EP1878791A1 Method for influenza virus purification |
| 01/16/2008 | EP1878720A1 Process for preparing chiral bicycloprolinates as intermediates for the preparation of peptidomimetic protease inhibitors |
| 01/16/2008 | EP1877549A2 Hiv vaccine |
| 01/16/2008 | EP1877548A2 Attenuated human parainfluenza virus, methods and uses thereof |
| 01/16/2008 | EP1281081B1 Method for determining biological agents in living target cells |
| 01/16/2008 | EP1098961B1 Interferon inducing genetically engineered attenuated viruses |
| 01/16/2008 | CN101104846A Physical deactivation method for recombined plant virus |
| 01/16/2008 | CN100362103C Human epidermis factor nucleic sequence and use thereof |
| 01/16/2008 | CN100362095C Composition and methods useful for HCV infection |
| 01/16/2008 | CN100361710C Construction and application of oncolytic adenovirus recombinant of tumor cell specifically expressing immunoregulation factor GM-CSF |
| 01/15/2008 | US7319092 Methods of suppressing microglial activation |
| 01/15/2008 | US7319002 Using 2-3,O-sialic acid immobilized solid support to detect adenoviral infection; pathogen diagnostics |
| 01/15/2008 | US7319001 Generating transgenic viral particle via enzymatic digestion, ligation and propagagtion in host |
| 01/15/2008 | US7318927 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 01/15/2008 | US7318919 Adenovirus vectors for gene therapy |
| 01/15/2008 | CA2205874C Lipid vesicles containing adeno-associated virus rep protein for transgene integration and gene therapy |
| 01/15/2008 | CA2093427C Molecular clones of hiv-1 and uses thereof |
| 01/10/2008 | WO2008004674A1 PRO-CLOTTING ENZYME, AND METHOD FOR DETECTION OF ENDOTOXIN OR (1→3)-β-D-GLUCAN USING THE SAME |
| 01/10/2008 | US20080010699 Lysophosphatidic acid acetyltransferases |
| 01/10/2008 | US20080010694 Method of acquiring immunological tolerance |
| 01/10/2008 | US20080009031 Mutant cells with altered sialic acid |
| 01/10/2008 | US20080008725 Influenza recombinant subunit vaccine |
| 01/10/2008 | US20080008717 Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus |
| 01/10/2008 | US20080008686 Tetracycline repressor regulated oncolytic viruses |
| 01/10/2008 | US20080008684 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 01/10/2008 | US20080008683 Polypeptide Sequence Involved in the Modulation of the Immunosuppresive Effect of Viral Proteins |
| 01/09/2008 | EP1876173A1 Chiral intermediates for the preparation of peptidomimetic protease inhibitors |
| 01/09/2008 | EP1874923A1 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof |
| 01/09/2008 | EP1874918A1 Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines |
| 01/09/2008 | EP1874345A2 Immunostimulatory compositions |
| 01/09/2008 | CN101103103A Recombinant influenza vectors with tandem transcription units |
| 01/09/2008 | CN101103102A Virus recovery medium, use thereof and viral diagnostic kit including same |
| 01/09/2008 | CN101100657A Method for large scale production of virus antigen |
| 01/09/2008 | CN101100656A Nephrotropic avian infectious bronchitis HN99 strain virus |
| 01/09/2008 | CN100360561C Barley yellow dwarf virus mediator ophid body and toxin transmission related protein and its application |
| 01/08/2008 | US7316898 Method of determining adenovirus particle concentration |
| 01/08/2008 | US7316813 Influenza vaccine composition |
| 01/08/2008 | CA2324028C Retroviral packaging cell line |
| 01/08/2008 | CA2228269C High efficiency helper system for aav vector production |
| 01/03/2008 | WO2008002673A2 Cell-free synthesis of virus like particles |
| 01/03/2008 | WO2006109174A3 Hiv vaccine comprising a glycoprotein 120 signal sequence with no more than one positively charged amino acid |
| 01/03/2008 | US20080004437 Cloned Genes Encoding Reverse Transcriptase lacking RNase H Activity |
| 01/03/2008 | US20080003659 Reversible Binding Surface |
| 01/03/2008 | US20080003658 Method for expression of small antiviral rna molecules within a cell |
| 01/03/2008 | US20080003657 Recombinant Rabies Virus Compositions |
| 01/03/2008 | US20080003229 the polypeptide induces an immune response directed both against the immunodominant region and against the protein of the host; vaccine |
| 01/03/2008 | US20080003200 Tissue selective binding for prostate and/or bone cancer, or adipose tissue; apoptosis induction; diagnosis, prognosis; staging metastatic cancer |
| 01/02/2008 | EP1871889A1 A process for producing modified reconstituted sendai viral envelope specific for drug and/or gene delivery to liver cells |
| 01/02/2008 | EP1871425A2 Defective sindbis viral vectors |
| 01/02/2008 | EP1129177B1 Avipox vector coding an hiv antigen and gamma-interferon |
| 01/02/2008 | EP0863987B1 Vectors and methods for gene transfer to cells |
| 01/02/2008 | CN101098959A Improved viral purification methods |
| 01/02/2008 | CN101098958A Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
| 01/02/2008 | CN101098882A Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 01/02/2008 | CN101096658A Chemical ablation method for recombinant plant virus |
| 01/01/2008 | US7314925 Vectors comprise avian lysozyme leader peptide for targetting the endoplasmic reticulum; heparin affinity chromatography |
| 01/01/2008 | US7314754 Polynucleotide encoding the hOT7T175 G protein coupled receptor |
| 01/01/2008 | US7314746 Apparatus and method for preparative scale purification of nucleic acids |
| 01/01/2008 | US7314715 Recombinant avian herpesvirus useful in vaccine production |
| 01/01/2008 | US7314710 Method for replicating the hepatitis C virus |
| 01/01/2008 | US7314631 Chimeric viral particle for use as tool in the prevention and treatment of bacterial and viral disease in humans |
| 01/01/2008 | US7314628 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 12/27/2007 | WO2007147528A1 Process for producing poxviruses and poxvirus compositions |
| 12/27/2007 | US20070298464 Methods of producing erythropoietin isoforms comprising Lewis-X structures and high sialic acid content and compositions of the same |
| 12/27/2007 | US20070298054 genetically stable vaccinia viruses and vaccinia virus vectors with higher safety, which undergo reversion with difficulty because of the removal of a gene involved in reversion from an attenuated smallpox vaccinia virus LC16m8 strain or its parental LC16mO strain, which tends to undergo reverse mutation |
| 12/27/2007 | CA2656259A1 Process for producing poxviruses and poxvirus compositions |
| 12/26/2007 | EP1869471A2 Method for porcine circovirus production and assays for monitoring production |
| 12/26/2007 | EP1869226A2 Viral nucleoprotein detection using an ion channel switch biosensor |
| 12/26/2007 | EP1869225A2 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 12/26/2007 | EP1869171A1 Virus purification using ultrafiltration |
| 12/26/2007 | EP1868654A2 Seneca valley virus based compositions and methods for treating disease |
| 12/26/2007 | CN101094920A Regulation of transcription with a cis-acting ribozyme |
| 12/26/2007 | CN101094915A Process for the production of an influenza vaccine |
| 12/26/2007 | CN101092636A Selectively replicating viral vectors |
| 12/26/2007 | CN101092609A Vaccine against mumps containing a JERYL-LYNN virus strain |
| 12/25/2007 | US7313357 Method for typing and detecting HBV |
| 12/25/2007 | US7312064 Expression vector for use as transformation and gene expression tool in genetic engineering; minimum plasmid-based system for the generation of infectious RNA viruses, preferably influenza viruses, from cloned DNA |
| 12/25/2007 | US7312030 Monitoring capability of genetically engineered arterivirus to propagate in cells; viricides; veterinary medicine; genetic vaccines |
| 12/25/2007 | US7311921 Effective against FIVDix, FIVUK8, FIVBang, FIVAom1, FIVAom2, FIVPet, and FIVShi. |
| 12/21/2007 | WO2007146197A1 Methods and reagents for virus isolation and detection |
| 12/21/2007 | WO2007144150A1 Processes for packaging oligonucleotides into virus-like particles of rna bacteriophages |
| 12/21/2007 | WO2007143858A1 Dph2 gene deletion mutant and uses thereof |
| 12/21/2007 | WO2006099592A3 Mannose immunogens for hiv-1 |
| 12/21/2007 | CA2655565A1 Dph2 gene deletion mutant and uses thereof |
| 12/21/2007 | CA2655108A1 Processes for packaging oligonucleotides into virus-like particles of rna bacteriophages |
| 12/20/2007 | US20070293448 Synthetic gagpol genes and their uses |
| 12/20/2007 | US20070292947 Novgel methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| 12/20/2007 | US20070292917 Composition and methods for expressing reporter molecules in mammalian cells |
| 12/20/2007 | US20070292840 Replication Competent Hepatitis C Virus and Methods of Use |